30
Participants
Start Date
May 12, 2008
Primary Completion Date
August 27, 2008
Study Completion Date
GSK256073
GSK256073 100 mg study drug
GSK Investigational Site, Baltimore
Lead Sponsor
GlaxoSmithKline
INDUSTRY